Market Value5,296,462,962
Total Holdings54
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KNTE / Kinnate Biopharma Inc.
IGMS / IGM Biosciences, Inc.
CVAC / CureVac N.V.
ELVN / Enliven Therapeutics, Inc.
RXST / RxSight, Inc.
DICE / DICE Therapeutics Inc
PLRX / Pliant Therapeutics, Inc.
AADI / Aadi Bioscience, Inc.
CTKB / Cytek Biosciences, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
IMGN / ImmunoGen, Inc.
BIIB / Biogen Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
AXSM / Axsome Therapeutics, Inc.
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
ETNB / 89bio, Inc.
TALS / Talaris Therapeutics Inc
ITOS / iTeos Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
GHRS / GH Research PLC
INBX.V / Inhibrx, Inc.
ANTX / AN2 Therapeutics, Inc.
MLYS / Mineralys Therapeutics, Inc.
ABOS / Acumen Pharmaceuticals, Inc.
STSA / Satsuma Pharmaceuticals Inc
CLDX / Celldex Therapeutics, Inc.
/ Fusion Networks Holdings, Inc.
HLVX / HilleVax, Inc.
ENTX / Entera Bio Ltd.
CELC / Celcuity Inc.
CLYM / Climb Bio, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
FDMT / 4D Molecular Therapeutics, Inc.
GERN / Geron Corporation
RNA / Avidity Biosciences, Inc.
FULC / Fulcrum Therapeutics, Inc.
WVE / Wave Life Sciences Ltd.
VRDN / Viridian Therapeutics, Inc.
NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant
NAMS / NewAmsterdam Pharma Company N.V.
EYPT / EyePoint Pharmaceuticals, Inc.
ALPN / Alpine Immune Sciences, Inc.
NSTG / NanoString Technologies, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
PCVX / Vaxcyte, Inc.
ACRV / Acrivon Therapeutics, Inc.
SPRY / ARS Pharmaceuticals, Inc.
TYRA / Tyra Biosciences, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
PEPG / PepGen Inc.
HOWL / Werewolf Therapeutics, Inc.
TNYA / Tenaya Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
BDTX / Black Diamond Therapeutics, Inc.
SLDB / Solid Biosciences Inc.
BLU / BluEnergies Ltd.
DSGN / Design Therapeutics, Inc.
ICVX / Icosavax, Inc.
AVTE / Aerovate Therapeutics, Inc.
NKTX / Nkarta, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
VOR / Vor Biopharma Inc.
JANX / Janux Therapeutics, Inc.